Iceland News Journal
SEE OTHER BRANDS

The most trusted news from Iceland

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland News Journal.

Triple-Track Investment Portfolio: LifeScience Compliance Platform, TV series, and Cat-Human Vocalization

Triple-Track Investment Portfolio: LifeScience Compliance Platform, TV series, and Cat-Human Vocalization

FGC 2.3 Feline Vocalization, Skyward Dragons, and a New Global Regulatory-Affairs SaaS Marketplace NEW YORK CITY, FL, UNITED STATES, June 26, 2025 /⁨EINPresswire.com⁩/ -- Visionary physician-scientist and entrepreneur Dr. Vlad Reznikov, MD, PhD,...

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays...

Amaroq presents Nalunaq 2024 Exploration Results

Amaroq presents Nalunaq 2024 Exploration Results

Reykjavík, Feb. 27, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Amaroq presents Nalunaq 2024 Exploration Results ** Highly Encouraging Underground Exploration Results and Continued Expansion of Key Mineralized Veins...

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update

Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to...

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, 2025. The event highlighted the use of optical...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...

Awards under Restricted Share Unit Plan

Awards under Restricted Share Unit Plan

Reykjavík, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Awards under Restricted Share Unit Plan (the “RSU”) TORONTO, ONTARIO – 12 February 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mining...

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...

Greenland Ice Melt Soars 17x Due to Extreme Heat

Greenland Ice Melt Soars 17x Due to Extreme Heat

(MENAFN) During an extraordinary May heatwave, Greenland's ice sheet experienced melting at a rate 17 times higher than usual, according to findings released Wednesday by the World Weather Attribution (WWA) network. “Temperatures over Iceland as...

From Knowledge to Power: Co-management, Knowledge Co-production, and the Re-empowerment of Arctic Indigenous Peoples

From Knowledge to Power: Co-management, Knowledge Co-production, and the Re-empowerment of Arctic Indigenous Peoples

Back to Publications A map of the U.S. Federal Subsistence Management Program Regional Advisory Council Regions and hub communities as established by ANILCA in 1980. Photo: U.S. Federal Subsistence Management Program Regional Advisory Council The...

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech...

Amaroq Announces Market-Making Arrangements with Arion bank

Amaroq Announces Market-Making Arrangements with Arion bank

Reykjavík, Jan. 24, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Amaroq Announces Market-Making Arrangements with Arion bank TORONTO, ONTARIO – 24 January 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent...

Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt

Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt

REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company, has completed a comprehensive refinancing of its capital...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...

AirAsia partners with Plan3 to transform the passenger experience during flight disruptions

AirAsia partners with Plan3 to transform the passenger experience during flight disruptions

Enhancing Passenger Support with Innovative Disruption Management Solutions. REYKJAVIK, 105, ICELAND, February 13, 2025 /⁨EINPresswire.com⁩/ -- Flight delays and cancellations affect hundreds of millions of passengers each year, costing the global...

Amaroq Awarded Johan Dahl Land Licence and Positive Initial Exploration Results

Amaroq Awarded Johan Dahl Land Licence and Positive Initial Exploration Results

Reykjavík, Jan. 22, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Amaroq Awarded Johan Dahl Land Licence and Positive Initial Exploration Results ** Expanding Presence across the South Greenland Copper Belt** **Results...

Appointment of Head of Business Development and Corporate Affairs

Appointment of Head of Business Development and Corporate Affairs

Reykjavik, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Appointment of Head of Business Development and Corporate Affairs TORONTO, ONTARIO – 21 January 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a...

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...

High Protein Yogurts Global Market To Reach $56.54 Billion By 2029

High Protein Yogurts Global Market To Reach $56.54 Billion By 2029

The Business Research Company’s High Protein Yogurts Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 11, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s...

Holding(s) in Company

Holding(s) in Company

Reykjavik, Jan. 10, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions